Cite
Discovery of novel 3-(1H-pyrazol-4-yl)-1H-indazole derivatives as potent type II TRK inhibitors against acquired resistance.
MLA
Qin, Qiaohua, et al. “Discovery of Novel 3-(1H-Pyrazol-4-Yl)-1H-Indazole Derivatives as Potent Type II TRK Inhibitors against Acquired Resistance.” European Journal of Medicinal Chemistry, vol. 264, Jan. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2023.115953.
APA
Qin, Q., Guo, Z., Lu, S., Wang, X., Fu, Q., Wu, T., Sun, Y., Liu, N., Zhang, H., Zhao, D., & Cheng, M. (2024). Discovery of novel 3-(1H-pyrazol-4-yl)-1H-indazole derivatives as potent type II TRK inhibitors against acquired resistance. European Journal of Medicinal Chemistry, 264, N.PAG. https://doi.org/10.1016/j.ejmech.2023.115953
Chicago
Qin, Qiaohua, Zhiqiang Guo, Shuyu Lu, Xin Wang, Qinglin Fu, Tianxiao Wu, Yixiang Sun, et al. 2024. “Discovery of Novel 3-(1H-Pyrazol-4-Yl)-1H-Indazole Derivatives as Potent Type II TRK Inhibitors against Acquired Resistance.” European Journal of Medicinal Chemistry 264 (January): N.PAG. doi:10.1016/j.ejmech.2023.115953.